SRC and systemic sclerosis: In addition, anti-AT1R and anti-ETAR IgG derived from SSc patients with SRC were found to trigger human microvascular endothelial cell proliferation through the mitogen-activated protein kinase pathway, with the subsequent activation of the E26 transformation-specific-1 transcription factor and the induction of tissue factor promoter [88].